| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$91,104 ) |
| | 2023 | 2020 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R33DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 000 | 2 | NIH | 3/13/2023 | -$68,259 |
| | 2023 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 5 | NIH | 3/9/2023 | -$22,845 |
|
| Issue Date FY: 2020 ( Subtotal = -$97,667 ) |
| | 2020 | 2020 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R33DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 002 | 2 | NIH | 5/7/2020 | -$377,257 |
| | 2020 | 2020 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R33DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 004 | 2 | NIH | 6/2/2020 | -$3,223 |
| | 2020 | 2020 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R33DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 001 | 2 | NIH | 3/27/2020 | $71,481 |
| | 2020 | 2020 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R33DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 000 | 2 | NIH | 12/12/2019 | $380,480 |
| | 2020 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 001 | 5 | NIH | 7/1/2020 | -$97,667 |
| | 2020 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R21DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 001 | 1 | NIH | 3/27/2020 | -$71,481 |
| | 2020 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R21DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 000 | 1 | NIH | 12/12/2019 | $0 |
| | 2020 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 5 | NIH | 2/26/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = -$680,784 ) |
| | 2019 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R21AI109439 | T cell driven antigen discovery for vaccine candidates for human Chagas disease | 000 | 2 | NIH | 5/6/2019 | -$5 |
| | 2019 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R01DA023281 | MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | 000 | 10 | NIH | 11/2/2018 | -$514,779 |
| | 2019 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 000 | 2 | NIH | 10/23/2018 | -$165,956 |
| | 2019 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 11350 SW VILLAGE PKWY | PORT SAINT LUCIE | FL | 34987-2352 | SAINT LUCIE | USA | R21CA191351 | LMTK3 inhibitors for the treatment of breast cancer | 000 | 2 | NIH | 12/3/2018 | -$44 |
|
| Issue Date FY: 2018 ( Subtotal = $958,161 ) |
| | 2018 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R21DA044425 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects | 000 | 1 | NIH | 9/19/2018 | $376,000 |
| | 2018 | 2018 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 5 | NIH | 2/13/2018 | $586,693 |
| | 2018 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA023281 | MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | 000 | 10 | NIH | 7/12/2018 | $0 |
| | 2018 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 000 | 2 | NIH | 7/30/2018 | $0 |
| | 2018 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA023281 | MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | 002 | 10 | NIH | 8/29/2018 | $1 |
| | 2018 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R21AI119288 | Novel cyclic lipopeptides for treating gram negative bacterial infections | 000 | 2 | NIH | 11/20/2017 | -$4,532 |
| | 2018 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R21CA181863 | Dual PPARgamma/RXRalpha activator as novel anti-breast cancer therapy | 000 | 2 | NIH | 4/17/2018 | $0 |
| | 2018 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01AR066676 | HTS for selective inhibitors of Meprin alpha and beta | 002 | 1 | NIH | 5/23/2018 | -$1 |
|
| Issue Date FY: 2017 ( Subtotal = $2,176,200 ) |
| | 2017 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 001 | 2 | NIH | 5/22/2017 | $71,400 |
| | 2017 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 000 | 2 | NIH | 3/21/2017 | $642,612 |
| | 2017 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R21AI109439 | T cell driven antigen discovery for vaccine candidates for human Chagas disease | 000 | 2 | NIH | 11/18/2016 | $227,500 |
| | 2017 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 4 | NIH | 2/21/2017 | $584,371 |
| | 2017 | 2017 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA023281 | MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | 001 | 10 | NIH | 8/30/2017 | $652,346 |
| | 2017 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R21AI109150 | Screening of Combinatorial Libraries for Complement C5 Inhibitors | 000 | 2 | NIH | 9/15/2017 | -$2,028 |
| | 2017 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA031370 | High throughput in vivo screening: translational generation of novel analgesics | 000 | 5 | NIH | 9/29/2017 | $0 |
| | 2017 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01DA023281 | MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | 000 | 9 | NIH | 12/30/2016 | -$1 |
| | 2017 | 2014 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC. | 3550 GENERAL ATOMICS CT | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R01HL104232 | Therapeutic Opportunities of Targeting Tissue Factor Signaling in Obesity | 000 | 4 | NIH | 2/14/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $2,147,554 ) |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21AI109439 | T cell driven antigen discovery for vaccine candidates for human Chagas disease | 000 | 1 | NIH | 12/18/2015 | $273,000 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 001 | 1 | NIH | 9/8/2016 | $0 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R01DA040882 | NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3 | 000 | 1 | NIH | 7/1/2016 | $742,361 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21CA191351 | LMTK3 inhibitors for the treatment of breast cancer | 000 | 2 | NIH | 6/13/2016 | $199,275 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21AI119288 | Novel cyclic lipopeptides for treating gram negative bacterial infections | 000 | 2 | NIH | 6/29/2016 | $252,175 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 3 | NIH | 2/18/2016 | $590,333 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21CA181863 | Dual PPARgamma/RXRalpha activator as novel anti-breast cancer therapy | 001 | 2 | NIH | 2/15/2016 | $23,751 |
| | 2016 | 2016 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21CA181863 | Dual PPARgamma/RXRalpha activator as novel anti-breast cancer therapy | 000 | 2 | NIH | 11/17/2015 | $213,759 |
| | 2016 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R01AR066676 | HTS for selective inhibitors of Meprin alpha and beta | 000 | 1 | NIH | 6/22/2016 | -$147,100 |
|
| Issue Date FY: 2015 ( Subtotal = $2,063,910 ) (Continued on the next page) |
| | 2015 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21AI119288 | Novel cyclic lipopeptides for treating gram negative bacterial infections | 000 | 1 | NIH | 6/15/2015 | $222,958 |
| | 2015 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R21CA191351 | LMTK3 inhibitors for the treatment of breast cancer | 000 | 1 | NIH | 6/25/2015 | $239,730 |
| | 2015 | 2015 | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 3550 GENERAL ATOMICS COURT | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R01AI105836 | Novel RORgamma antagonists for inflammation and autoimmune disease | 000 | 2 | NIH | 2/12/2015 | $580,731 |
|
